key: cord-285051-jmdfyydc authors: Fan, Wen-juan; Liu, Xiao-ling title: Effect of advanced nursing care on psychological disorder in patients with COVID-19: A protocol of systematic review date: 2020-07-02 journal: Medicine (Baltimore) DOI: 10.1097/md.0000000000021026 sha: doc_id: 285051 cord_uid: jmdfyydc BACKGROUND: This study will explore the effect of advanced nursing care (ANC) on psychological disorder (PD) in patients with Coronavirus Disease 2019 (COVID-19). METHODS: This study will search the following electronic databases up to June 30, 2020: Cochrane Library, PUBMED, EMBASE, PsycINFO, Web of Science, OpenGrey, Cumulative Index to Nursing and Allied Health Literature, CNKI, and WANGFANG. We will not impose any language limitations. Two authors will independently identify titles/abstracts and full-text of all potential studies, and will collect data from eligible studies. Additionally, study quality will be assessed by Cochrane risk of bias. If necessary, we will conduct meta-analysis if sufficient trials are included. RESULTS: This study will explore the effect of ANC on PD in patients with COVID-19 through outcome indicators. CONCLUSION: The findings of this study may supply summarized evidence of ANC for the management of PD in COVID-19. PROSPERO REGISTRATION NUMBER: PROSPERO CRD42020187610. Coronavirus Disease 2019 (COVID-19) is a rapid, global spread virus, [1] [2] [3] [4] which attacks people in almost all countries worldwide. [5] [6] [7] [8] So far, only its transmission in China has been controlled. [9, 10] The rate of its infections outside China is still rapidly increasing, especially in the United States, which accounts for almost one-third of all patients with COVID-19 globally. [11, 12] Till May 25, 2020, about 5,586,715 cases of COVID-19 and 347,852 deaths have been reported. [12] A variety of studies reported that patients who received or even cured with this condition often experience psychological disorder (PD), including depression, and anxiety. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] So the effective prevention and treatment of PD in patients with COVID-19 are very essential task. Studies suggested that advanced nursing care (ANC) may benefit PD in patients with COVID-19. [25] [26] [27] [28] However, no systematic review has investigated this issue. Therefore, this study will aim to assess the effect of ANC on managing PD in patients with COVID-19. This study was registered through PROSPERO (CRD42020187610). It is reported in accordance with the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocol statement. 2.2. Eligibility criteria 2.2.1. Study types. The present study will include randomized controlled trials (RCTs) on investigating the effect of ANC on PD in patients with COVID-19, irrespective language, and publication status. In the experimental group, all patients received ANC on PD in patients with COVID-19. In the control group, no restrictions related to the comparators are applied. However, we will not consider any controls involved in ANC. This study will include patients with COVID-19, who were diagnosed as PD, regardless sex, race, age, and severity of PD. This study is financially supported by Yan'an Science and Technology Research and Development Plan Project (2018KS-27). The supporter will not take part in whole process of this study. 2.2.4. Outcome measurements. Primary outcomes are depression and anxiety, as measured by any related scales reported in the primary trials. Secondary outcomes are pressure, panic disorder, quality of life, and expected and unexpected adverse events. We will search following electronic databases (Cochrane Library, PUBMED, EMBASE, PsycINFO, Web of Science, OpenGrey, Cumulative Index to Nursing and Allied Health Literature, CNKI and WANGFANG) up to June 30, 2020 without language and publication status restrictions. In addition, gray literatures will also be searched, including conference proceedings, reference lists of included studies, and websites of clinical trial registry. All potential RCTs of ANC on PD in patients with COVID-19 will be considered. The specifics of Cochrane Library are presented in Table 1 . We will modify similar search strategies to the other electronic databases. Two authors will independently scan the retrieved records based on titles/abstracts; and unrelated studies will be excluded. Then, we will read full articles of remaining studies in accordance with the full inclusion criteria. Each excluded study will be recorded with specific reason. The whole process of study selection will be shown in a flow chart. If any divergences occur, we will invite a third author to help solve them through discussion. Two authors will independently collect data from all eligible studies based on the data extraction form. It consists of following information: title, publication time, country, study design and setting, participant characteristics, eligible criteria, treatments and controls, outcomes, risk of bias, and other essential information. We will solve any different opinions by inviting another experienced author through discussion. Whenever the missing or unclear data are identified, we will contact original trial authors to request them. Otherwise, we will analyze the available data if we cannot achieve them. We will utilize Cochrane risk of bias tool to evaluate risk of bias for each included trial. Two authors will independently appraise it through 7 domains. We will make a judgment for each item using 1 of 3 categories (high, unclear, and low risk of bias). We will solve disagreements by consulting a third author. We will use RevMan 5.3 software to perform statistical analysis. All continuous data will be estimated as standardized mean difference and 95% confidence intervals (CIs), and all dichotomous data will be expressed as risk ratio and 95% CIs. All statistical heterogeneity is appraised by I 2 test. I 2 50% indicates minor heterogeneity, and a fixed-effect model will be applied. suggests obvious heterogeneity, and a random-effect model will be placed. If sufficient data are collected with minor heterogeneity, we will plan to conduct meta-analysis. If remarkable heterogeneity is detected, we will carry out subgroup analysis to test its heterogeneity sources. If necessary, we will report study results by narrative description. We will perform subgroup analysis according to the different details of interventions, study quality and outcome indicators. We will undertake sensitivity analysis to examine the robustness and stability of synthesized results by eliminating low-quality studies. We will detect reporting bias using Funnel plot and Egger regression test if >10 eligible studies are included. No ethics approval is required, since no individual patient data will be collected in this study. We will publish this study at a peerreviewed journal. COVID-19 is a globally spread disease, which attacks almost all countries. [1] [2] [3] [4] Studies reported that patients who experience or cured with COVID-19 often have PD. Thus, it is very important to manage such condition. Several studies reported that ANC can help patients with this disorder. However, no systematic review assessed its effects. Thus, this study is the first one to systematically and comprehensively appraise the effects of ANC on PD in patients with COVID-19. The results of this study may provide evidence to determine whether ANC is effective for the treatment of PD following COVID-19. MeSH descriptor: (randomized controlled trial) explode all trees 12 ((controlled trial * ) or (clinical trial * ) or (placebo * ) or (randomly * ) or (random * ) or (control * ) or (comparator * )):ti, ab, kw 13 Or 11-12 14 3 and 7 and 10 and 13 Fan and Liu Medicine (2020) 99: 27 Medicine An overview of COVID-19 Characterisation of COVID-19 pandemic in paediatric age group: a systematic review and meta-analysis COVID-19: review of epidemiology and potential treatments against 2019 novel coronavirus Comprehensive overview of COVID-19 based on current evidence Current epidemiological and clinical features of COVID-19; a global perspective from China The Coronavirus disease 2019 (COVID-19) pandemic Epidemiology and control of COVID-19 COVID-19: epidemiology, evolution, and cross-disciplinary perspectives COVID-19: lessons to date from China Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis COVID-19: The first documented coronavirus pandemic in history COVID-19 Coronvirus pandemic Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis Prevalence and influencing factors of anxiety and depression symptoms in the first-line medical staff fighting against COVID-19 in Gansu Anxiety and depression among general population in China at the peak of the COVID-19 epidemic Clinical analysis of suspected COVID-19 patients with anxiety and depression Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: the importance of gender Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain COVID-19 and depression Depression, dependence and prices of the COVID-19-Crisis Comparison of prevalence and associated factors of anxiety and depression among people affected by versus people unaffected by quarantine during the COVID-19 epidemic in Southwestern China Prevalence of self-reported depression and anxiety among pediatric medical staff members during the COVID-19 outbreak in Guiyang, China EDITORIAL: COVID-19 and Anxiety and Depression in Efficacy of internet-based integrated intervention on depression and anxiety symptoms in patients with COVID-19 Mental health status and intervention effects of cardiovascular nursing staff under the new coronavirus pneumonia epidemic Analysis of anxiety, depression level and influencing factors during isolation and observation of suspected patients with new coronavirus pneumonia Investigation on anxiety, depression and influencing factors of patients with new coronavirus pneumonia Anxiety and depression of elderly patients during the epidemic of new coronavirus pneumonia and its influencing factors The authors report no conflicts of interest.Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.